Evidence map›Paper›PMID 35643945›Full record

ArticleWorld journal of urology2022

The comprehensive complication index as a tool for reporting the burden of complications after mini-percutaneous nephrolithotomy: is it time to leave the Clavien-Dindo classification behind?

Luca Boeri, Matteo Turetti, Carlo Silvani, Irene Fulgheri, Letizia Maria Ippolita Jannello, Susanna Garbagnati, Matteo Malfatto, Gilda Galbiati, Efrem Pozzi, Stefano Paolo Zanetti and 5 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Luca BoeriDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy. dr.lucaboeri@gmail.com.ORCID http://orcid.org/0000-0003-0040-784X
Matteo TurettiDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Carlo SilvaniDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Irene FulgheriDepartment of Vascular Surgery, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Letizia Maria Ippolita JannelloDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Susanna GarbagnatiDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Matteo MalfattoDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Gilda GalbiatiDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Efrem PozziDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Stefano Paolo ZanettiDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Fabrizio LongoDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Elisa De LorenzisDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Giancarlo AlboDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Andrea SaloniaDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Emanuele MontanariDepartment of Urology, IRCCS Foundation Ca' Granda, Ospedale Maggiore Policlinico, Via della Commenda 15, 20122, Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milan · ITIRCCS Ospedale San Raffaele · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo validate the comprehensive complication index (CCI) for mini-percutaneous nephrolithotomy (mPCNL).

methodsData from 287 patients who underwent mPCNL were analyzed. Complications after mPCNL were classified using both the CCI and the Clavien-Dindo classification (CDC). Descriptive statistics and linear/logistic regression analyses detailed the association between clinical predictors and mPCNL outcomes.

resultsAfter mPCNL, 83 (28.9%) patients had complications, of which 12 (4.2%) patients with multiple complications had a higher CCI score compared to the traditional CDC system accounting only for the highest grade. The CCI enabled a more accurate prediction of length of stay (LOS) than CDC (CCI: r = 0.32; p < 0.01 vs. CDC: r = 0.26; p = 0.01). Patients with multiple complications had higher stone volume (p = 0.02), longer operative time and LOS (all p < 0.01). A higher rate of post-operative hospital readmission (33.3% vs. 9.9%, p = 0.02) and lower rate of stone free (33.3% vs. 64.7%, p = 0.04) were found in patients with multiple complications than in those with single complication. Linear regression analysis revealed that multiple complications were associated with longer LOS (p < 0.001) after accounting for BMI and stone volume. Similarly, having multiple complications was associated with fivefold higher risk of readmission (p = 0.02).

conclusionThe CCI is a valuable metric for assessing post-operative complications after mPCNL. The cumulative CCI is a better predictor of LOS than the CDC for mPCNL. Minor complications not captured by the highest CDC score are relevant since patients with multiple complications have longer LOS and higher rate of readmission than those with single ones.

Indexed as

Kidney CalculiNephrolithotomy, PercutaneousHumansLength of StayOperative TimePatient ReadmissionPostoperative ComplicationsTreatment OutcomeClavien–Dindo classificationComplicationsComprehensive complication indexPercutaneous nephrolithotomyStone

Identifiers

PMID35643945
PMCPMC9236985
OpenAlexW4281811020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.